PUBLISHER: IMARC | PRODUCT CODE: 1468495
PUBLISHER: IMARC | PRODUCT CODE: 1468495
Oral Proteins and Peptides Market by Drug Type (Linaclotide, Plecanatide, Calcitonin, Insulin, Octreotide), Application (Gastric and Digestive Disorders, Bone Diseases, Diabetes, Hormonal Disorders), and Region 2024-2032
The global oral proteins and peptides market size reached US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.3 Billion by 2032, exhibiting a growth rate (CAGR) of 7.51% during 2024-2032. The expanding prevalence of chronic diseases, the rising geriatric population, and the increasing preference for oral drugs among consumers represent some of the key factors driving the market.
Proteins and peptides are natural components of the human body and play essential roles in many biological processes. Due to their complex structure and susceptibility to digestion in the stomach and small intestine, they are usually administered through injections. However, oral proteins and peptides can be taken via the oral path to treat hormonal, gastric, and metabolic disorders. They are designed to overcome these challenges by using specialized formulations that protect the molecules from digestion and allow them to be absorbed through the intestinal wall into the bloodstream. These formulations include enteric coatings, nanoparticles, and other delivery technologies. Oral proteins and peptides are extensively utilized to treat numerous chronic diseases, such as diabetes, cancer, and autoimmune disorders.
Oral Proteins and Peptides Market Trends:
The increasing volume of patients suffering from chronic diseases, such as cancer, diabetes, cardiovascular disorders (CVDs), and acquired immunodeficiency syndrome (AIDs), and the expanding geriatric population represent the key factors driving the oral proteins and peptides market growth. Besides this, shifting preferences and the rising demand for effective oral drugs and technology among the masses are contributing to the market growth. Moreover, the escalating consumer health consciousness and the growing awareness of the numerous benefits associated with the consumption of oral protein and peptide supplements are creating a positive outlook for the market. In addition to this, innovative technological advancements, such as three-dimensional (3D) printing, nanotechnology, and genetic engineering, have enabled manufacturers to produce more advanced and cost-effective product variants, which is acting as another significant growth-inducing factor. Concurrent with this, the extensive collaborative efforts between pharmaceutical companies, significant advancements in the healthcare infrastructure, and rising research and development (R&D) activities are presenting remunerative growth opportunities for the market. Furthermore, the inflating disposable income of consumers, the widespread adoption of protein-rich diets, the surging demand for protein powder, bars, and shakes, and the increasing proliferation of online platforms providing easy product access are aiding in market expansion.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global oral proteins and peptides market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on drug type and application.
Drug Type Insights:
Linaclotide
Plecanatide
Calcitonin
Insulin
Octreotide
The report has provided a detailed breakup and analysis of the oral proteins and peptides market based on the drug type. This includes linaclotide, plecanatide, calcitonin, insulin, and octreotide. According to the report, insulin represented the largest segment.
Application Insights:
Gastric and Digestive Disorders
Bone Diseases
Diabetes
Hormonal Disorders
A detailed breakup and analysis of the oral proteins and peptides market based on the application has also been provided in the report. This includes gastric and digestive disorders, bone diseases, diabetes, and hormonal disorders. According to the report, diabetes accounted for the largest market share.
Regional Insights:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for oral proteins and peptides. Some of the factors driving the North America oral proteins and peptides market included the increasing prevalence of chronic diseases, the shifting consumer preference for oral drugs, and innovative product advancements.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global oral proteins and peptides market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Amryt Pharma Plc, AstraZeneca PLC, Biocon Limited, Novo Nordisk A/S, Oramed Ltd, Proxima Concepts Limited, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report:
- How has the global oral proteins and peptides market performed so far, and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global oral proteins and peptides market?
- What is the impact of each driver, restraint, and opportunity on the global oral proteins and peptides market?
- What are the key regional markets?
- Which countries represent the most attractive oral proteins and peptides market?
- What is the breakup of the market based on the drug type?
- Which is the most attractive drug type in the oral proteins and peptides market?
- What is the breakup of the market based on the application?
- Which is the most attractive application in the oral proteins and peptides market?
- What is the competitive structure of the global oral proteins and peptides market?
- Who are the key players/companies in the global oral proteins and peptides market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Oral Proteins and Peptides Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Drug Type
- 6.1 Linaclotide
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Plecanatide
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Calcitonin
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Insulin
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Octreotide
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
7 Market Breakup by Application
- 7.1 Gastric and Digestive Disorders
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Bone Diseases
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Diabetes
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Hormonal Disorders
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by Region
- 8.1 North America
- 8.1.1 United States
- 8.1.1.1 Market Trends
- 8.1.1.2 Market Forecast
- 8.1.2 Canada
- 8.1.2.1 Market Trends
- 8.1.2.2 Market Forecast
- 8.1.1 United States
- 8.2 Asia-Pacific
- 8.2.1 China
- 8.2.1.1 Market Trends
- 8.2.1.2 Market Forecast
- 8.2.2 Japan
- 8.2.2.1 Market Trends
- 8.2.2.2 Market Forecast
- 8.2.3 India
- 8.2.3.1 Market Trends
- 8.2.3.2 Market Forecast
- 8.2.4 South Korea
- 8.2.4.1 Market Trends
- 8.2.4.2 Market Forecast
- 8.2.5 Australia
- 8.2.5.1 Market Trends
- 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
- 8.2.6.1 Market Trends
- 8.2.6.2 Market Forecast
- 8.2.7 Others
- 8.2.7.1 Market Trends
- 8.2.7.2 Market Forecast
- 8.2.1 China
- 8.3 Europe
- 8.3.1 Germany
- 8.3.1.1 Market Trends
- 8.3.1.2 Market Forecast
- 8.3.2 France
- 8.3.2.1 Market Trends
- 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
- 8.3.3.1 Market Trends
- 8.3.3.2 Market Forecast
- 8.3.4 Italy
- 8.3.4.1 Market Trends
- 8.3.4.2 Market Forecast
- 8.3.5 Spain
- 8.3.5.1 Market Trends
- 8.3.5.2 Market Forecast
- 8.3.6 Russia
- 8.3.6.1 Market Trends
- 8.3.6.2 Market Forecast
- 8.3.7 Others
- 8.3.7.1 Market Trends
- 8.3.7.2 Market Forecast
- 8.3.1 Germany
- 8.4 Latin America
- 8.4.1 Brazil
- 8.4.1.1 Market Trends
- 8.4.1.2 Market Forecast
- 8.4.2 Mexico
- 8.4.2.1 Market Trends
- 8.4.2.2 Market Forecast
- 8.4.3 Others
- 8.4.3.1 Market Trends
- 8.4.3.2 Market Forecast
- 8.4.1 Brazil
- 8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast
9 Drivers, Restraints, and Opportunities
- 9.1 Overview
- 9.2 Drivers
- 9.3 Restraints
- 9.4 Opportunities
10 Value Chain Analysis
11 Porters Five Forces Analysis
- 11.1 Overview
- 11.2 Bargaining Power of Buyers
- 11.3 Bargaining Power of Suppliers
- 11.4 Degree of Competition
- 11.5 Threat of New Entrants
- 11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
- 13.1 Market Structure
- 13.2 Key Players
- 13.3 Profiles of Key Players
- 13.3.1 Amryt Pharma Plc
- 13.3.1.1 Company Overview
- 13.3.1.2 Product Portfolio
- 13.3.2 AstraZeneca PLC
- 13.3.2.1 Company Overview
- 13.3.2.2 Product Portfolio
- 13.3.2.3 Financials
- 13.3.2.4 SWOT Analysis
- 13.3.3 Biocon Limited
- 13.3.3.1 Company Overview
- 13.3.3.2 Product Portfolio
- 13.3.3.3 Financials
- 13.3.3.4 SWOT Analysis
- 13.3.4 Novo Nordisk A/S
- 13.3.4.1 Company Overview
- 13.3.4.2 Product Portfolio
- 13.3.4.3 Financials
- 13.3.4.4 SWOT Analysis
- 13.3.5 Oramed Ltd
- 13.3.5.1 Company Overview
- 13.3.5.2 Product Portfolio
- 13.3.5.3 Financials
- 13.3.6 Proxima Concepts Limited
- 13.3.6.1 Company Overview
- 13.3.6.2 Product Portfolio
- 13.3.1 Amryt Pharma Plc
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
List of Figures
- Figure 1: Global: Oral Proteins and Peptides Market: Major Drivers and Challenges
- Figure 2: Global: Oral Proteins and Peptides Market: Sales Value (in Billion US$), 2018-2023
- Figure 3: Global: Oral Proteins and Peptides Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 4: Global: Oral Proteins and Peptides Market: Breakup by Drug Type (in %), 2023
- Figure 5: Global: Oral Proteins and Peptides Market: Breakup by Application (in %), 2023
- Figure 6: Global: Oral Proteins and Peptides Market: Breakup by Region (in %), 2023
- Figure 7: Global: Oral Proteins and Peptides (Linaclotide) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 8: Global: Oral Proteins and Peptides (Linaclotide) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 9: Global: Oral Proteins and Peptides (Plecanatide) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 10: Global: Oral Proteins and Peptides (Plecanatide) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 11: Global: Oral Proteins and Peptides (Calcitonin) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 12: Global: Oral Proteins and Peptides (Calcitonin) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 13: Global: Oral Proteins and Peptides (Insulin) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 14: Global: Oral Proteins and Peptides (Insulin) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 15: Global: Oral Proteins and Peptides (Octreotide) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 16: Global: Oral Proteins and Peptides (Octreotide) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 17: Global: Oral Proteins and Peptides (Gastric and Digestive Disorders) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 18: Global: Oral Proteins and Peptides (Gastric and Digestive Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 19: Global: Oral Proteins and Peptides (Bone Diseases) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 20: Global: Oral Proteins and Peptides (Bone Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 21: Global: Oral Proteins and Peptides (Diabetes) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 22: Global: Oral Proteins and Peptides (Diabetes) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 23: Global: Oral Proteins and Peptides (Hormonal Disorders) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 24: Global: Oral Proteins and Peptides (Hormonal Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 25: North America: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
- Figure 26: North America: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 27: United States: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
- Figure 28: United States: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 29: Canada: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
- Figure 30: Canada: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 31: Asia-Pacific: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
- Figure 32: Asia-Pacific: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 33: China: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
- Figure 34: China: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 35: Japan: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
- Figure 36: Japan: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 37: India: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
- Figure 38: India: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 39: South Korea: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
- Figure 40: South Korea: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 41: Australia: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
- Figure 42: Australia: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 43: Indonesia: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
- Figure 44: Indonesia: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 45: Others: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
- Figure 46: Others: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 47: Europe: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
- Figure 48: Europe: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 49: Germany: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
- Figure 50: Germany: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 51: France: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
- Figure 52: France: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 53: United Kingdom: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
- Figure 54: United Kingdom: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 55: Italy: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
- Figure 56: Italy: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 57: Spain: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
- Figure 58: Spain: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 59: Russia: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
- Figure 60: Russia: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 61: Others: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
- Figure 62: Others: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 63: Latin America: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
- Figure 64: Latin America: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 65: Brazil: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
- Figure 66: Brazil: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 67: Mexico: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
- Figure 68: Mexico: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 69: Others: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
- Figure 70: Others: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 71: Middle East and Africa: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
- Figure 72: Middle East and Africa: Oral Proteins and Peptides Market: Breakup by Country (in %), 2023
- Figure 73: Middle East and Africa: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 74: Global: Oral Proteins and Peptides Industry: Drivers, Restraints, and Opportunities
- Figure 75: Global: Oral Proteins and Peptides Industry: Value Chain Analysis
- Figure 76: Global: Oral Proteins and Peptides Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Oral Proteins and Peptides Market: Key Industry Highlights, 2023 & 2032
- Table 2: Global: Oral Proteins and Peptides Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
- Table 3: Global: Oral Proteins and Peptides Market Forecast: Breakup by Application (in Million US$), 2024-2032
- Table 4: Global: Oral Proteins and Peptides Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 5: Global: Oral Proteins and Peptides Market: Competitive Structure
- Table 6: Global: Oral Proteins and Peptides Market: Key Players
